Table 7.

Immune-histochemical results and statistical analyses of AR considered as dichotomized variable as for both cases and controls datasets

IHC parameter	Cut-off	Case dataset (primary ovarian lesions) (%)	Control dataset (primary ovarian lesions) (%)	pValue (Cases vs controls: IHC comparison)	OR (Cases vs controls) (CI 95%)
AR	<  1%	7/39 (17.9)	2/40 (5)	0.087
	≥ 1%	32/39 (82.1)	38/40 (95)
	<  10%	26/39 (66.7)	7/40 (17.5)	< 0.001	9.429 (3.290–27.020)
	≥ 10%	13/39 (33.3)	33/40 (82.5)
	IRS ≤ 2	31/39 (79.5)	13/40 (32.5)	< 0.001
	IRS > 2	8/39 (20.5)	27/40 (67.5)

AR Androgen Receptor